Arca
Skip to content

BD Insyte™ IV Catheter

Catheter, Intravascular, Therapeutic, Short-Term Less Than 30 Days. 510(k) K252137, from Becton Dickinson Infusion Therapy Systems, Inc. (Sandy, UT). Product code FOZ, class 2.

As of Nov 16, 2026, K252137 is an FDA 510(k) held by Becton Dickinson Infusion Therapy Systems, Inc., substantially equivalent on Apr 2, 2026 after 268 days, with no recalls tied to it in FDA's recall database.

  • Substantially equivalent: Apr 2, 2026
  • Review time: 268 days
  • Recalls: 0

Indications for Use

As the 510(k) summary states them, read from FDA's summary PDF

BD Insyte™ IV Catheter is intended to be inserted into a patient’s peripheral vascular system for short term use to sample blood, monitor blood pressure, or administer fluids. These devices may be used for any patient population with consideration given to adequacy of vascular anatomy, procedure being performed, fluids being infused, and duration of therapy.

Predicate Devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF

Other FOZ Clearances

The newest 510(k)s for the same product code; their median review was 202 days; see every FOZ device

Record

Type
Traditional
Received
Jul 8, 2025
Review panel
General Hospital
Regulation
21 CFR 880.5200

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.